The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until September, 2020.
Horizon: Validation of an improved method for rapid characterization of protein aggregates in biologic drugs for increased quality and safetySBC: OPTOFLUIDICS, INC. Topic: NA
Optofluidics and the University of Delaware propose to complete the development of the Horizon technology and carry out validation via a comprehensive multi-site study. The technology is a subvisible particle analyzer pioneered during Phase I. The technology is designed to fill two critical gaps in biopharmaceutical product development: (1) Scientists can count and image particles with current too ...SBIR Phase II 2017 Department of CommerceNational Institute of Standards and Technology
SBC: STAR CRYOELECTRONICS LLC Topic: 9020868TT
X-ray fluorescence spectroscopy is a widely used and extremely sensitive analytical technique for qualitative and quantitative chemical analysis. Superconducting Transition Edge Sensor (TES) microcalorimeter detectors have now been developed that achieve an energy resolution of 2 eV for 1.5 keV X-rays, which is sufficient to enable the measurement of the small shift of the X-ray line position that ...SBIR Phase II 2013 Department of CommerceNational Institute of Standards and Technology
SBC: Prime Synthesis Topic: 9021168R
Since 1990, Prime Synthesis, Inc. (PSI) has been a leading manufacturer of controlled pore glass (CPG). It has developed significant expertise in the optimization of physical characteristics and chemical modifications of CPG for a variety of applications. CPG has a unique combination of attributes including a very uniform, three-dimensional, nanopore structure that is dimensionally stable in organ ...SBIR Phase I 2013 Department of CommerceNational Institute of Standards and Technology